GHHealthcareLarge-Cap
Guardant Health, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Guardant Health, Inc. (GH), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are GH insiders buying or selling?
Guardant Health, Inc. insiders reported 8 open-market buys ($65.2M) and 245 sells ($2.9B) across 253 Form 4 filings — a net selling position of $2.8B.
Source: SEC EDGAR Form 4
Key Statistics (as of Aug 24, 2026)
Total Form 4 filings
253
SEC EDGAR
Insider filers
23
Insider buys (8)
$65.2M
Insider sells (245)
$2.9B
Insider sentiment
Net sellingNet insider flow of $2.8B in net selling.
Recent GH insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 24, 2026 | Amirali Talasaz | Co-Chief Executive Officer | Sale | 37.5K | $169.16 | $6.3M |
| Aug 18, 2026 | Musa Tariq | Director | Sale | 116 | $156.45 | $18.1K |
| Aug 13, 2026 | Terilyn J. Monroe | Chief People Officer | Sale | 46.3K | $165.12 | $7.6M |
| Aug 11, 2026 | Chris Freeman | Chief Commercial Officer | Sale | 63.6K | $169.58 | $10.8M |
| Aug 6, 2026 | Medina Manuel Hidalgo | Director | Sale | 1.7K | $164.24 | $279.2K |
| Aug 5, 2026 | Ian T Clark | Director | Sale | 14.2K | $158.92 | $2.3M |
| Jul 16, 2026 | Musa Tariq | Director | Sale | 116 | $163.29 | $18.9K |
| Jun 30, 2026 | Kumud Kalia | Chief Information Officer | Sale | 600 | $131.18 | $78.7K |
| Jun 30, 2026 | Amirali Talasaz | Co-Chief Executive Officer | Sale | 260.0K | $151.20 | $39.3M |
| Jun 23, 2026 | Musa Tariq | Director | Sale | 2.0K | $131.16 | $255.9K |
| Jun 23, 2026 | Myrtle S Potter | Director | Sale | 1.6K | $131.16 | $204.1K |
| Jun 16, 2026 | Musa Tariq | Director | Sale | 116 | $130.19 | $15.1K |
| Jun 15, 2026 | Kumud Kalia | Chief Information Officer | Sale | 3.4K | $130.24 | $445.2K |
| Jun 12, 2026 | Kumud Kalia | Chief Information Officer | Sale | 5.0K | $130.41 | $652.0K |
| Jun 8, 2026 | Eltoukhy Helmy | Co-Chief Executive Officer | Sale | 100.0K | $126.30 | $12.6M |
| Jun 8, 2026 | Michael Brian Bell | Chief Financial Officer | Sale | 2.0K | $128.62 | $257.2K |
| Jun 5, 2026 | Steve E. Krognes | Director | Sale | 9.3K | $132.51 | $1.2M |
| Jun 4, 2026 | Meghan V. Joyce | Director | Sale | 10.0K | $126.98 | $1.3M |
| May 29, 2026 | Medina Manuel Hidalgo | Director | Sale | 1.0K | $130.06 | $130.1K |
| May 28, 2026 | John G. Saia | Chief Legal Officer | Sale | 10.0K | $125.08 | $1.3M |
| May 26, 2026 | Chris Freeman | Chief Commercial Officer | Sale | 24.4K | $118.67 | $2.9M |
| May 22, 2026 | John G. Saia | Chief Legal Officer | Sale | 20.0K | $106.51 | $2.1M |
| May 22, 2026 | Amirali Talasaz | Co-Chief Executive Officer | Sale | 210.0K | $109.89 | $23.1M |
| May 22, 2026 | Ian T Clark | Director | Sale | 6.9K | $106.90 | $735.0K |
| May 22, 2026 | Medina Manuel Hidalgo | Director | Sale | 1.3K | $107.09 | $133.9K |
Showing the 25 most recent of 253 Form 4 filings for Guardant Health, Inc..
Most active GH insiders
- Ian T Clark42 filings
- Amirali Talasaz41 filings
- Stanley J Meresman36 filings
- Eltoukhy Helmy23 filings
- Musa Tariq21 filings
Ask anything about GH insider activity
Use Trabud's AI agent to query Guardant Health, Inc.'s Form 4 history in plain English — "Show me GH CEO purchases this year" or compare it against any other ticker.
Open the AI agentGH insider trading FAQ
Are Guardant Health, Inc. insiders buying or selling?
Across 253 SEC Form 4 filings, Guardant Health, Inc. (GH) insiders reported 8 open-market purchases totaling $65.2M and 245 sales totaling $2.9B. That is a net selling position of $2.8B.
How many insiders trade GH stock?
23 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Guardant Health, Inc.. The most recent filing was accepted on Aug 24, 2026.
Where does Trabud get GH insider trading data?
All GH insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.